Clinical experience with estramustine phosphate and predinimustine, two steroidal alkylating agents compounds
Catane, R.
Cancer Treatment Reports 62(8): 1264-1265
1978
ISSN/ISBN: 0361-5960 PMID: 688269 Document Number: 3883
Document emailed within 1 workday
Related Documents
Mittelman, A.; Catane, R.; Murphy, G.P. 1977: New steroidal alkylating agents in advanced stage D carcinoma of the prostate Cancer Treatment Reports 61(2): 307-310Van Poppel, H.; Werbrouck, P.W.; Baert, L. 1990: Effect of estramustine phosphate on free androgens. a comparative study of the effect of orchiectomy and estramustine phosphate on free androgens in patients with prostatic cancer Acta Urologica Belgica 58(4): 89-95
Nishio, S.; Kishimoto, T.; Maekawa, M.; Kawakita, J.; Hayahara, N.; Yuki, K.; Morikawa, Y.; Yasumoto, R.; Kato, Y.; Funai, K. 1986: Clinical effects of estramustine phosphate disodium (Estracyt) on prostatic cancer Hinyokika Kiyo. Acta Urologica Japonica 32(11): 1763-1770
Awakura, Y.; Yamamoto, M.; Fukuzawa, S.; Itoh, N.; Nonomura, M.; Fukuyama, T. 2000: Clinical evaluation of estramustine phosphate and vinblastine in patients with hormone-refractory prostate cancer Hinyokika Kiyo. Acta Urologica Japonica 46(7): 449-452
Levy, R.; le Maignan, C.; N'Daw, D.; Andrieu, J.M. 1997: An equivalent of anti-androgen withdrawal syndrome: decrease of prostate specific antigen and clinical response to estramustine phosphate withdrawal Presse Medicale 26(13): 611
Sakamoto, H.; Ohtani, K.; Kawamori, J.; Shirakawa, T.; Ohta, H.; Igarashi, N.; Tochigi, M.; Furuya, K.; Tsubata, K.; Tanaka, Y. 1995: Intralymphatic administration of estramustine phosphate Nihon Sanka Fujinka Gakkai Zasshi 47(11): 1271-1272
Buckner, J.C.; Moynihan, T.J. 2001: The DNA-repair gene MGMT and the clinical response of gliomas to alkylating agents New England Journal of Medicine 344(9): 686; Author Reply 687-688
Weissmann, G. 1979: Different effects of steroidal and non-steroidal anti-inflammatory agents on inflammation Reumatizam 26(6): 207-214
Spears, C.P. 1981: Nucleophilic selectivity ratios of model and clinical alkylating agents by 4-(4'-nitrobenzyl)pyridine competition Molecular Pharmacology 19(3): 496-504
Edsmyr, F.; Esposti, P.L.; Andersson, L. 1980: Estramustine phosphate therapy in poorly differentiated carcinoma of the prostate Scandinavian Journal of Urology and Nephrology. Supplementum 55: 139-142
Gustafson, A.; Persson, B.; Tisell, L.E.; Wiklund, O.; Ohlson, R. 1977: Treatment of oral estramustine phosphate (Estracyt) in prostatic carcinoma: influences on lipid and carbohydrate metabolism Investigative Urology 15(3): 220-224
Zgradić, I. 1987: The effect of estramustine phosphate on carcinoma cell proliferation depends on the estrogen receptor status in the cytosol Godisnjak Vojnomedicinske Akademije 29: 77-81
Sinibaldi, V.J.; Carducci, M.; Laufer, M.; Eisenberger, M. 1999: Preliminary evaluation of a short course of estramustine phosphate and docetaxel (Taxotere) in the treatment of hormone-refractory prostate cancer Seminars in Oncology 26(5 Suppl 17: 45-48
Spiro, T.; Liu, L.; Gerson, S. 2000: New cytotoxic agents for the treatment of metastatic malignant melanoma: temozolomide and related alkylating agents in combination with guanine analogues to abrogate drug resistance Forum 10(3): 274-285
Weissbach, L. 1992: Prospective randomized multicenter phase IIi study of treatment of hormone refractory prostatic cancer: mitomycin C vs. 4-epirubicin vs. estramustine phosphate Der Urologe. Ausg. a 31(1): 62
Eklöv, S.; Mahdy, E.; Wester, K.; Björk, P.; Malmström, P.U.; Busch, C.; Nilsson, S. 1996: Estramustine-binding protein (EMBP) content in four different cell lines and its correlation to estramustine induced metaphase arrest Anticancer Research 16(4a): 1819-1822
Fernández-Viadero, C.; Verduga, R.; Soto, J.; Alsar, M.J. 1993: The use of topical non-steroidal anti-inflammatory agents in elderly patients taking oral anticoagulation agents Medicina Clinica 100(5): 196-197
Pukhal'skiĭ, A.L.; Mezhneva, A.P.; Pevnitskiĭ, L.A. 1988: Sensitivity of the splenic cells of different mouse strains to the antiproliferative action of alkylating compounds Biulleten' Eksperimental'noi Biologii i Meditsiny 105(2): 196-198
Schmidt, C.G. 1971: Alkylating cytostatic agents Der Internist 12(Suppl 1): 119-127
Frei, E. 1991: The modulation of alkylating agents Seminars in Hematology 28(3 Suppl 4: 22-24